S&P 500   3,936.97
DOW   32,030.11
QQQ   306.12
3 Dividend Contenders to Buy Now for Long-Term Gains Later
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
3 Tech Stocks Well Positioned For Growth At A Reasonable Price
These 3 Dividend Growers Yield More Than the 10-Year Note
Could This Be The Biggest Stock Of 2023? (Ad)pixel
Closing prices for crude oil, gold and other commodities
Seesaw Effect: As Banks Drop, These 3 Stocks Are Going Up
The 1 Stock To Watch In This Market. (Ad)pixel
AI Is Giving 3 Marketing & Ad Firms Revenue & Earnings Boost
GameStop Shares Surge On Surprise Profit
S&P 500   3,936.97
DOW   32,030.11
QQQ   306.12
3 Dividend Contenders to Buy Now for Long-Term Gains Later
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
3 Tech Stocks Well Positioned For Growth At A Reasonable Price
These 3 Dividend Growers Yield More Than the 10-Year Note
Could This Be The Biggest Stock Of 2023? (Ad)pixel
Closing prices for crude oil, gold and other commodities
Seesaw Effect: As Banks Drop, These 3 Stocks Are Going Up
The 1 Stock To Watch In This Market. (Ad)pixel
AI Is Giving 3 Marketing & Ad Firms Revenue & Earnings Boost
GameStop Shares Surge On Surprise Profit
S&P 500   3,936.97
DOW   32,030.11
QQQ   306.12
3 Dividend Contenders to Buy Now for Long-Term Gains Later
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
3 Tech Stocks Well Positioned For Growth At A Reasonable Price
These 3 Dividend Growers Yield More Than the 10-Year Note
Could This Be The Biggest Stock Of 2023? (Ad)pixel
Closing prices for crude oil, gold and other commodities
Seesaw Effect: As Banks Drop, These 3 Stocks Are Going Up
The 1 Stock To Watch In This Market. (Ad)pixel
AI Is Giving 3 Marketing & Ad Firms Revenue & Earnings Boost
GameStop Shares Surge On Surprise Profit
S&P 500   3,936.97
DOW   32,030.11
QQQ   306.12
3 Dividend Contenders to Buy Now for Long-Term Gains Later
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
3 Tech Stocks Well Positioned For Growth At A Reasonable Price
These 3 Dividend Growers Yield More Than the 10-Year Note
Could This Be The Biggest Stock Of 2023? (Ad)pixel
Closing prices for crude oil, gold and other commodities
Seesaw Effect: As Banks Drop, These 3 Stocks Are Going Up
The 1 Stock To Watch In This Market. (Ad)pixel
AI Is Giving 3 Marketing & Ad Firms Revenue & Earnings Boost
GameStop Shares Surge On Surprise Profit
NASDAQ:GBIO

Generation Bio - GBIO Stock Forecast, Price & News

$3.88
-0.02 (-0.51%)
(As of 03/22/2023 12:00 AM ET)
Add
Compare
Today's Range
$3.78
$4.00
50-Day Range
$3.61
$7.01
52-Week Range
$3.40
$9.59
Volume
187,353 shs
Average Volume
225,503 shs
Market Capitalization
$231.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.31

Generation Bio MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
217.2% Upside
$12.31 Price Target
Short Interest
Bearish
2.69% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$24,514 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.14) to ($1.88) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.36 out of 5 stars

Medical Sector

238th out of 986 stocks

Pharmaceutical Preparations Industry

100th out of 477 stocks


GBIO stock logo

About Generation Bio (NASDAQ:GBIO) Stock

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Receive GBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Generation Bio and its competitors with MarketBeat's FREE daily newsletter.

GBIO Stock News Headlines

Could This Be The Biggest Stock Of 2023?
This Little Known Company Has Been Growing It's Revenue By Over 100% Year Over Year!pixel
Needham Keeps Their Buy Rating on Generation Bio (GBIO)
The Stock That Is Flying Under Wall St. Radar
With The Founder OF XPO Logistics Leading The Way This Nasdaq Company is Ready and GOING!pixel
GBIO Generation Bio Co.
See More Headlines
Receive GBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Generation Bio and its competitors with MarketBeat's FREE daily newsletter.

GBIO Company Calendar

Last Earnings
11/10/2021
Today
3/22/2023
Next Earnings (Estimated)
5/04/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:GBIO
Fax
N/A
Employees
150
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$12.31
High Stock Price Forecast
$24.00
Low Stock Price Forecast
$2.23
Forecasted Upside/Downside
+217.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$-136,640,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$4.75 per share

Miscellaneous

Free Float
47,315,000
Market Cap
$231.52 million
Optionable
Not Optionable
Beta
1.95

Key Executives

  • Dr. Cameron Geoffrey McDonough M.D. (Age 53)
    Pres, CEO, Sec. & Director
    Comp: $935.37k
  • Dr. Matthew Norkunas M.B.A. (Age 45)
    M.D., Chief Financial Officer
    Comp: $604.16k
  • Dr. Matthew Stanton Ph.D. (Age 50)
    Chief Scientific Officer
    Comp: $647.42k
  • Dr. Douglas Kerr M.B.A. (Age 56)
    M.D., Ph.D., Chief Medical Officer
    Comp: $651.64k
  • Dr. Tracy Zimmermann Ph.D. (Age 53)
    Chief Devel. Officer
    Comp: $590.56k
  • Dr. Mark D. Angelino Ph.D. (Age 50)
    Co-Founder
  • Dr. Robert Kotin Ph.D. (Age 67)
    Co-Founder & Advisor
  • Ms. Antionette Paone M.B.A. (Age 45)
    M.S., Chief Operating Officer
  • Dr. Jennifer Elliott Esq.
    J.D., Ph.D., Chief Legal Officer
  • Dr. Phillip Samayoa Ph.D.
    Chief Strategy Officer













GBIO Stock - Frequently Asked Questions

Should I buy or sell Generation Bio stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Generation Bio in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" GBIO shares.
View GBIO analyst ratings
or view top-rated stocks.

What is Generation Bio's stock price forecast for 2023?

5 Wall Street analysts have issued 12 month price targets for Generation Bio's stock. Their GBIO share price forecasts range from $2.23 to $24.00. On average, they anticipate the company's stock price to reach $12.31 in the next twelve months. This suggests a possible upside of 217.2% from the stock's current price.
View analysts price targets for GBIO
or view top-rated stocks among Wall Street analysts.

How have GBIO shares performed in 2023?

Generation Bio's stock was trading at $3.93 at the beginning of the year. Since then, GBIO shares have decreased by 1.3% and is now trading at $3.88.
View the best growth stocks for 2023 here
.

When is Generation Bio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our GBIO earnings forecast
.

How were Generation Bio's earnings last quarter?

Generation Bio Co. (NASDAQ:GBIO) released its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.56) earnings per share for the quarter, missing the consensus estimate of ($0.54) by $0.02.

What ETF holds Generation Bio's stock ?

Fidelity Blue Chip Growth ETF holds 849 shares of GBIO stock, representing 0.00% of its portfolio.

What other stocks do shareholders of Generation Bio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Generation Bio investors own include DocuSign (DOCU), NVIDIA (NVDA), Overstock.com (OSTK), Boeing (BA), Pure Storage (PSTG), Mastercard (MA), QUALCOMM (QCOM), Riot Platforms (RIOT), Twilio (TWLO) and Enphase Energy (ENPH).

When did Generation Bio IPO?

(GBIO) raised $126 million in an IPO on Friday, June 12th 2020. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, Jefferies and Cowen served as the underwriters for the IPO and Wedbush PacGrow was co-manager.

What is Generation Bio's stock symbol?

Generation Bio trades on the NASDAQ under the ticker symbol "GBIO."

Who are Generation Bio's major shareholders?

Generation Bio's stock is owned by a number of retail and institutional investors. Top institutional investors include Price T Rowe Associates Inc. MD (12.22%), T. Rowe Price Investment Management Inc. (6.02%), Geode Capital Management LLC (1.46%), Bank of America Corp DE (1.46%), Morgan Stanley (0.83%) and JPMorgan Chase & Co. (0.78%). Insiders that own company stock include Antoinette Paone, Charles A Rowland Jr, Donald William Nicholson, Douglas Kerr, Evan Spiegel, Geoff Mcdonough, James E Flynn, Jason P Rhodes, Matthew Stanton, Phillip Samayoa and Venture Associates X L Atlas.
View institutional ownership trends
.

How do I buy shares of Generation Bio?

Shares of GBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Generation Bio's stock price today?

One share of GBIO stock can currently be purchased for approximately $3.88.

How much money does Generation Bio make?

Generation Bio (NASDAQ:GBIO) has a market capitalization of $231.52 million. The company earns $-136,640,000.00 in net income (profit) each year or ($2.35) on an earnings per share basis.

How many employees does Generation Bio have?

The company employs 150 workers across the globe.

How can I contact Generation Bio?

Generation Bio's mailing address is 301 BINNEY STREET, CAMBRIDGE MA, 02142. The official website for the company is generationbio.com. The company can be reached via phone at 617-655-7500 or via email at investors@generationbio.com.

This page (NASDAQ:GBIO) was last updated on 3/23/2023 by MarketBeat.com Staff